المؤلفون: Kadouh, Nour K., Elijah, Joseph, Fitzgerald, Linda J., Phan, Hanna

المصدر: Pediatric Pulmonology ; volume 58, issue 12, page 3393-3402 ; ISSN 8755-6863 1099-0496

الاتاحة: http://dx.doi.org/10.1002/ppul.26396
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.26396

المؤلفون: Elijah, Joseph, Fitzgerald, Linda J., Phan, Hanna

المصدر: Pediatric Pulmonology ; volume 58, issue 12, page 3377-3385 ; ISSN 8755-6863 1099-0496

الاتاحة: http://dx.doi.org/10.1002/ppul.26706
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.26706

المؤلفون: Elijah, Joseph, Fitzgerald, Linda J., Phan, Hanna

المصدر: Pediatric Pulmonology ; volume 58, issue 12, page 3386-3392 ; ISSN 8755-6863 1099-0496

الاتاحة: http://dx.doi.org/10.1002/ppul.26698
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.26698

المؤلفون: Xu-Stettner, Jiashan, Thompson, Amy N., Fitzgerald, Linda J., Licari, Tracy, McMurry, Katie A., Tischer, Sarah

المصدر: Progress in Transplantation ; volume 33, issue 2, page 156-161 ; ISSN 1526-9248 2164-6708

الاتاحة: https://doi.org/10.1177/15269248231164161
https://journals.sagepub.com/doi/pdf/10.1177/15269248231164161
https://journals.sagepub.com/doi/full-xml/10.1177/15269248231164161

المؤلفون: Jia, Shijing, Wang, Yizhuo, Ross, Melissa H, Zuckerman, Jonathan B, Murray, Susan, Han, MeiLan K, Cahalan, Shannon E, Lenhan, Blair E, Best, Ryan N, Taylor-Cousar, Jennifer L, Simon, Richard H, Fitzgerald, Linda J, Troost, Jonathan P, Sood, Suman L, Gifford, Alex H

المساهمون: Cystic Fibrosis Foundation

المصدر: Journal of Cystic Fibrosis ; ISSN 1569-1993

الاتاحة: http://dx.doi.org/10.1016/j.jcf.2024.03.002
https://api.elsevier.com/content/article/PII:S1569199324000304?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1569199324000304?httpAccept=text/plain

المؤلفون: Linder, Kathleen A, Patel, Twisha S, Kauffman, Carol A, Fitzgerald, Linda J, Miceli, Marisa H

المصدر: Open Forum Infectious Diseases ; volume 6, issue Supplement_2, page S636-S636 ; ISSN 2328-8957

مصطلحات موضوعية: Infectious Diseases, Oncology

الاتاحة: http://dx.doi.org/10.1093/ofid/ofz360.1599
http://academic.oup.com/ofid/article-pdf/6/Supplement_2/S636/30270473/ofz360.1599.pdf

المؤلفون: Xu-Stettner, Jiashan, Thompson, Amy N., Fitzgerald, Linda J., Licari, Tracy, McMurry, Katie A., Tischer, Sarah

مصطلحات موضوعية: 111099 Nursing not elsewhere classified, FOS: Clinical medicine, 110323 Surgery, FOS: Health sciences, 110305 Emergency Medicine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::286f5b100e75fa0c8d60307756ab8706

المؤلفون: Lipp, Madeline A, Crass, Ryan L, Fitzgerald, Linda J, Patel, Twisha S, Simon, Richard H, Lenhan, Blair E, Han, MeiLan K, Jia, Shijing

المصدر: Journal of Antimicrobial Chemotherapy ; volume 77, issue 9, page 2516-2521 ; ISSN 0305-7453 1460-2091

مصطلحات موضوعية: Infectious Diseases, Pharmacology (medical), Pharmacology, Microbiology (medical)

الاتاحة: http://dx.doi.org/10.1093/jac/dkac187
https://academic.oup.com/jac/article-pdf/77/9/2516/45536499/dkac187.pdf

المؤلفون: Linder, Kathleen A., Kauffman, Carol A., Patel, Twisha S., Fitzgerald, Linda J., Richards, Blair J., Miceli, Marisa H.

مصطلحات موضوعية: antifungal prophylaxis, aspergillosis, Candida infection, invasive fungal infections, lung transplant recipients, Microbiology and Immunology, Medicine (General), Health Sciences

وصف الملف: application/pdf

Relation: Linder, Kathleen A.; Kauffman, Carol A.; Patel, Twisha S.; Fitzgerald, Linda J.; Richards, Blair J.; Miceli, Marisa H. (2021). "Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation." Transplant Infectious Disease 23(1): n/a-n/a.; https://hdl.handle.net/2027.42/166427; Transplant Infectious Disease; Pennington KM, Razonable RR, Peters S, et al. Why do lung transplant patients discontinue triazole prophylaxis? Transpl Infect Dis. 2019; 21: e13067.; Steinbach WJ, Marr KA, Anaissie EJ, et al. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. J Infection. 2012; 65: 453 ‐ 464.; Husain S, Zaldonis D, Kusne S, et al. Variation in antifungal strategies in lung transplantation. Transpl Infect Dis. 2006; 8: 213 ‐ 218.; Chong PP, Kennedy CC, Hathcock MA, et al. Epidemiology of invasive fungal infections in lung transplant recipients on long‐term azole prophylaxis. Clin Transpl. 2015; 29: 311 ‐ 318.; Pennington KM, Yost KJ, Escalante P, Razonable RR, Kennedy CC. Antifungal prophylaxis in lung transplant: a survey of United States’ transplant centers. Clin Transpl. 2019; 33: e13630.; Segal B, Herbrecht R, Stevens D, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis. 2008; 47: 674 ‐ 683.; De Pauw B, Walsh T, Donnelly J, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group. Clin Infect Dis. 2008; 46: 1813 ‐ 1821.; Ljungman P, Boeckh M, Hirsch HH, et al. Definitions of CMV infection and disease in transplant patients for use in clinical trials. Clin Infect Dis. 2017; 64: 87 ‐ 91.; Hosseini‐Moghaddam SM, Ouédraogo A, Naylor KL, et al. Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: a population‐based cohort study. Transpl Infect Dis. 2020;. https://doi.org/10.1111/TID.13250; Baker AW, Maziarz EK, Arnold CJ, et al. Invasive fungal infection after lung transplantation: epidemiology in the setting of antifungal prophylaxis. Clin Infect Dis. 2020; 70: 30 ‐ 39.; Singh N, Paterson DL Aspergillus infections in transplant recipients. Clinical Microbiol Rev. 2005; 18: 44 ‐ 69.; Solé A, Morant P, Salavert M, et al. Aspergillus infections in lung transplant recipients: risk factors and outcome. Clin Microbiol Infect. 2005; 11: 359 ‐ 365.; Husain S, Sole A, Alexander BD, et al. The 2015 International society for heart and lung transplantation guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: executive summary. J Heart Lung Transpl. 2016; 35: 261 ‐ 282.; Smith J, Andes D. Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamics considerations. Ther Drug Monit. 2008; 30: 167 ‐ 172.; Patterson TF, Thompson GR III, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016; 63 ( 4 ): e1 ‐ e60.; Ashbee HR, Barnes RA, Johnson EM, Richardson MD, Gorton R, Hope WW. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society of Medical Mycology. J Antimicrob Chemother. 2014; 69: 1162 ‐ 1176.; Kozuch JM, Feist A, Yung G, et al. Low dose posaconazole delayed release tablets for fungal prophylaxis in lung transplant recipients. Clin Transplant. 2018; 32: e13300. https://doi.org/10.1111/ctr.13300; Samanta P, Clancy CJ, Marini RV, et al. Isavuconazole is as effective as and better tolerated than voriconazole for antifungal prophylaxis in lung transplant recipients. Clin Infect Dis. 2020; ciaa652. https://doi.org/10.1093/cid/ciaa652; Vianello F, Fiscon M, Loy M, Rea F, Sgarabotto D. Nebulized liposomal amphotericin prophylaxis in lung transplantation: shall we take it or leave it? Transpl Internat. 2016; 29: 1053 ‐ 1054.; Polverino E, Rosales‐Mayor E, Dale GE, Dembowsky K, Torres A. The role of neutrophil elastase inhibitors in lung disease. Chest. 2017; 152: 249 ‐ 262.; Wilkinson TS, Conway Morris A, Kefala K, et al. Ventilator‐associated pneumonia is characterized by excessive release of neutrophil proteases in the lung. Chest. 2012; 142: 1425 ‐ 1432.; Greene C, Taggart C, Lowe G, Gallagher P, McElvaney N, O’Neill S. Local impairment of anti‐neutrophil elastase capacity in community‐acquired pneumonia. J Infect Dis. 2003; 188: 769 ‐ 776.; Tanash HA, Riise GC, Hansson L, Nilsson PM, Piitulainen E. Survival benefit of lung transplantation in individuals with severe α 1 ‐anti‐trypsin deficiency (PiZZ) and emphysema. J Heart Lung Transpl. 2011; 30: 1342 ‐ 1347.; Penninga L, Moller CH, Penninga EI, Iversen M, Gluud C, Steinbruchel DA. Antibody induction therapy for lung transplant recipients. Cochrane Database Syst Rev. 2013; 11:CD008927.; Whitson BA, Lehman A, Wehr A, et al. To induce or not to induce: a 21 st century evaluation of lung transplant immunosuppression’s effect on survival. Clin Transpl. 2014; 28: 450 ‐ 461.; Martín‐Mateos RM, Graus J, Albillos A, et al. Initial immunosuppression with or without basiliximab: a comparative study. Transpl Proc. 2012; 44: 2570 ‐ 2572.; Kovac D, Kotnik V, Kandus A. Basiliximab and mycophenolate mofetil in combination with low‐dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant patients. Transpl Proc. 2005; 37: 4230 ‐ 4234.; Bennett D, Fossi A, Marchetti L, et al. Postoperative acute kidney injury in lung transplant recipients. Interact Cardiovasc Thorac Surg. 2019; 28: 929 ‐ 935.; Gavalda J, Len O, San Juan R, et al. Risk Factors for Invasive aspergillosis in solid‐organ transplant recipients: a case‐control study. Clin Infect Dis. 2005; 41: 52 ‐ 59.; Aguilar CA, Hamandi B, Fegbeutel C, et al. Clinical risk factors for invasive aspergillosis in lung transplant recipients: results of an international cohort study. J Heart Lung Transpl. 2018; 37: 1226 ‐ 1234.; Wahidi MM, Willner DA, Snyder LD, Hardison JL, Chia JY, Palmer SM. Diagnosis and outcome of early pleural space infection following lung transplantation. Chest. 2009; 135: 484 ‐ 491.; Arthurs SK, Eid AJ, Deziel PJ, et al. The impact of invasive fungal diseases on survival after lung transplantation. Clin Transpl. 2010; 24: 341 ‐ 348.; Doligalski CT, Benedict K, Cleveland AA, et al. Epidemiology of invasive mold infections in lung transplant recipients. Am J Transpl. 2014; 14: 1328 ‐ 1393.; Husain S, Camargo JF. Invasive aspergillosis in solid‐organ transplant recipients: guidelines from the American Society of Transplantation Infectious Disease Community of Practice. Clin Transpl. 2019; 33: e13544.; Pappas P, Alexander B, Andes D, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant‐Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010; 50: 1101 ‐ 1111.; Andes DR, Safdar N, Baddley JW, et al. The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant‐Associated Infection Surveillance Network (TRANSNET). Transpl Infect Dis. 2016; 18: 921 ‐ 931.; Neoh CF, Snell GI, Kotsimbos T, et al. Antifungal prophylaxis in lung transplantation – a world‐wide survey. Am J Transpl. 2011; 11 ( 2 ): 361 ‐ 366.

الاتاحة: https://hdl.handle.net/2027.42/166427
https://doi.org/10.1111/tid.13448

المؤلفون: Ky, Trung Q., Park, Jeong M., McMurry, Katie A., Tischer, Sarah M., Fitzgerald, Linda J., Cotiguala, Laura

مصطلحات موضوعية: antifungal prophylaxis, renal transplant, oropharyngeal candidiasis, nystatin, kidney transplant, esophageal candidiasis, thrush, Microbiology and Immunology, Medicine (General), Health Sciences

وصف الملف: application/pdf

Relation: Ky, Trung Q.; Park, Jeong M.; McMurry, Katie A.; Tischer, Sarah M.; Fitzgerald, Linda J.; Cotiguala, Laura (2021). "Oropharyngeal candidiasis outcomes in renal transplant recipients receiving nystatin versus no antifungal prophylaxis." Transplant Infectious Disease (3): n/a-n/a.; https://hdl.handle.net/2027.42/168352; Transplant Infectious Disease; Al‐Mohaya MA, Darwazeh A, Al‐Khudair W. Oral fungal colonization and oral candidiasis in renal transplant patients: the relationship to Miswak use. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 93 ( 4 ): 455 ‐ 460.; Sikora MB, Truax C, Lee S, et al. Low‐dose fluconazole prophylaxis in kidney transplant recipients receiving tacrolimus. Clin Transplant. 2012; 26 ( 5 ): 555 – 560.; Dongari‐Bagtzoglou A, Dwivedi P, Ioannidou E, Shaqman M, Hull D, Burleson J. Oral Candida infection and colonization in solid organ transplant recipients. Oral Microbiol Immunol. 2009; 24 ( 3 ): 249 ‐ 254.; Alangaden GJ, Thyagarajan R, Gruber SA, et al. Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clin Transplant. 2006; 20 ( 4 ): 401 ‐ 409.; Gombert ME, Dubouchet L, Aulicino TM, Butt KMH. A comparative trial of clotrimazole troches and oral nystatin suspension in recipients of renal transplants: use in prophylaxis of oropharyngeal candidiasis. JAMA. 1987; 258 ( 18 ): 2553 ‐ 2555.; Gupta KL, Ghosh AK, Kochhar R, Jha V, Chakrabarti A, Sakhuja V. Esophageal candidiasis after renal transplantation: comparative study in patients on different immunosuppressive protocols. Am J Gastroenterol. 1994; 89 ( 7 ): 1062 ‐ 1065.; Guerra CM, Formica RN, Kulkarni S, Asch WS, Tichy EM. Duration of prophylaxis against fungal infection in kidney transplant recipients. Prog Transplant. 2015; 25 ( 4 ): 311 ‐ 315.; Owens NJ, Nightingale CH, Schweizer RT, Schauer PK, Dekker PT, Quintiliani R. Prophylaxis of oral candidiasis with clotrimazole troches. Arch Intern Med. 1984; 144 ( 2 ): 290 ‐ 293.; Coronado‐Castellote L, Jiménez‐Soriano Y. Clinical and microbiological diagnosis of oral candidiasis. J Clin Exp Dent. 2013; 5 ( 5 ): 279 ‐ 286.; López‐Pintor RM, Hernández G, de Arriba L, de Andrés A. Oral candidiasis in patients with renal transplants. Med Oral Patol Oral Cir Bucal. 2013; 18 ( 3 ): 381 – 387.; Güleç ATülin, Demirbilek M, Seçkin D, et al. Superficial fungal infections in 102 renal transplant recipients: a case‐control study. J Am Acad Dermatol. 2003; 49 ( 2 ): 187 ‐ 192.; Morales JM, Varo E, Lázaro P. Immunosuppressant treatment adherence, barriers to adherence and quality of life in renal and liver transplant recipients in Spain. Clin Transplant. 2012; 26 ( 2 ): 369 ‐ 376.; Chisholm MA. Identification of medication‐adherence barriers and strategies to increase adherence in recipients of renal transplants. Manag Care Interface. 2004; 17: 44.; Chisholm‐Burns MA, Spivey CA, Graff Zivin J, Lee JK, Sredzinski E, Tolley EA. Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. Am J Transplant. 2013; 13 ( 9 ): 2364 ‐ 2373.; Vasquez E, Pollak R, Benedetti E. Clotrimazole increases tacrolimus blood levels: a drug interaction in kidney transplant patients. Clin Transplant. 2001; 15 ( 2 ): 95 ‐ 99.; Manez R, Martin M, Raman D, et al. Fluconazole therapy in transplant recipients receiving FK506. Transplantation. 1994; 57 ( 10 ): 1521 ‐ 1523.; Chapman JR. The KDIGO clinical practice guidelines for the care of kidney transplant recipients. Transplantation. 2010; 89 ( 6 ): 644 ‐ 645.

الاتاحة: https://hdl.handle.net/2027.42/168352
https://doi.org/10.1111/tid.13559

المؤلفون: Real, Maria, Kachulis, Bessie, King, Christopher S., Licker, Marc J., McIlroy, David R., Nair, Priya, Pasero, Daniela, Pilcher, David, Rex, Steffen, Royston, David, Slinger, Peter, Valenza, Franco, Walker, Chris, Arcadipane, Antonio, Bastien, Oliver, Bekkers, Joseph A., Bettex, Dominique, Caliandro, Francesca, Dal Checco, Erika, Davis, Robert Duane, Dellgren, Goran, Espinoza, Andreas, Felten, Marie Louise, Feltracco, Paolo, Fischler, Marc, Fitzgerald, Linda J., Forner, Ana Flo, Fragata, Isabel, Roman, Ana Gonzalez, Harris, Paul, Hommel, Matthias, Lees, Nicholas J., Le Guen, Morgan, Leone, Marc, Lepoivre, Thierry, Marcucci, Carlo, Martelli, Sabina, Michel-Cherqui, Mireille, Molitoris, Ulrich, ŞENTÜRK, Nüzhet Mert, Schwarzenberger, Johanna, Turan, Sema, Valchanov, Kamen, Valentine, Vincent G., von Homeyer, Peter, Vuylsteke, Alain, Weig, Thomas, Zarragoikoetxea, Iratxe, Zenz, Sebastian, Falcoz, Pierre-Emmanuel, Inci, Ilhan, Roscoe, Andrew, Rozec, Bertrand, Sale, Shiva M., Sanchez, Juan F., Montravers, Philippe, Mosca, Roberto, Parizkova, Barbora, Prabhu, Mahesh, Pugliese, Francesco, Raman, Sanjeev M., Ramos, Cristina, Ranieri, Vito Marco, Ricksten, Sven-Erik, Marczin, Nandor, de Waal, Eric E. C., Hopkins, Peter M. A., Mulligan, Michael S., Simon, Andre, Shaw, Andrew D., Van Raemdonck, Dirk, Neyrinck, Arne, Gries, Cynthia J., Algotsson, Lars, Szegedi, Laszlo, von Dossow, Vera, Burrell, Aidan, Carmona, Paula, Greenhalgh, Donna, Hoechter, Dominik

المساهمون: 3388508

مصطلحات موضوعية: CERRAHİ, Göğüs Hastalıkları ve Allerji, Kardiyoloji, Cerrahi Tıp Bilimleri, Surgery, Cardiology and Cardiovascular Medicine, Transplantation, Respiratory Care, Pulmonary and Respiratory Medicine, Health Sciences, CARDIAC ve CARDIOVASCULAR SİSTEMLER, Klinik Tıp, Klinik Tıp (MED), SOLUNUM SİSTEMİ, TRANSPLANTASYON, Tıp, Sağlık Bilimleri, Dahili Tıp Bilimleri

Relation: JOURNAL OF HEART AND LUNG TRANSPLANTATION; Marczin N., de Waal E. E. C. , Hopkins P. M. A. , Mulligan M. S. , Simon A., Shaw A. D. , Van Raemdonck D., Neyrinck A., Gries C. J. , Algotsson L., et al., "International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document", JOURNAL OF HEART AND LUNG TRANSPLANTATION, cilt.40, sa.11, ss.1327-1348, 2021; av_ad3ee22a-15ec-44ae-af75-7da5e471d08e; vv_1032021; http://hdl.handle.net/20.500.12627/179585; https://doi.org/10.1016/j.healun.2021.07.012; 40; 11; 1327; 1348

الاتاحة: https://hdl.handle.net/20.500.12627/179585
https://doi.org/10.1016/j.healun.2021.07.012

المؤلفون: Combs, Michael P, Fitzgerald, Linda J, Wakeam, Elliot, Lyu, Dennis M, O'Dwyer, David N

المصدر: Annals of the American Thoracic Society; Feb2022, Vol. 19 Issue 2, p335-338, 4p

المؤلفون: Hurst, Thomas E.¹, Fitzgerald, Linda J.², Chan, Kevin M.³, DeGeorge, Christina⁴, Patil, Preethi¹, Gianchandani, Roma⁴

المصدر: Trends in Transplantation. Jun2019, Vol. 12 Issue 2, p1-4. 4p.

مصطلحات موضوعية: *LUNG transplantation, *DIABETES, *DISEASE prevalence, *BODY mass index, *COMPLICATIONS from organ transplantation, *MORTALITY